Health
Drug to treat OCD could reduce hospitalisation risk in Covid patients, study in Lancet says – ThePrint
The study says antidepressant fluvoxamine could reduce the production of inflammatory molecules called cytokines that can be…
New Delhi: Fluvoxamine, an antidepressant used for the treatment of major depressive disorders and obsessive-compulsive disorder (OCD), can reduce the need for hospitalisation among high-risk Covid-19 patients, according to the results of a new clinical…
-
Noosa News15 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business17 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
Noosa News17 hours agoBrisbane news live: 80,000 green bins rolled out | Residents told to prepare for ‘violent’ summer storms | Council declares water safe for swimming despite dead fish
-
General17 hours agoDay of pain: sirens ring out to mark attack on Israel